News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>CICC Adds CSPC PHARMA's TP to HKD8.6; 1Q25 Results in Line
CSPC PHARMA (01093.HK) reported 1Q25 results that met expectations, according to CICC's research report.During the period, the company's revenue declined by 21.9% YoY but i...
Reset
Send
The window will close in 5 seconds
<Research>CICC Adds CSPC PHARMA's TP to HKD8.6; 1Q25 Results in Line
Close
Recommend
13
Positive
15
Negative
8
 
SHORT SELL
 
STOCK INFO

CSPC PHARMA (01093.HK)  -0.090 (-1.092%)    Short selling $321.76M; Ratio 29.326%   reported 1Q25 results that met expectations, according to CICC's research report.

During the period, the company's revenue declined by 21.9% YoY but increased by 10.9% QoQ to RMB7.02 billion, net profit dropped by 8.4% YoY but rose by 168.7% QoQ to RMB1.48 billion, and core net profit fell by 18.2% YoY but climbed by 106.2% QoQ to RMB1.41 billion.

Related NewsBOCOMI: Southbound Funds Focus on Healthcare/ Financial Sectors in Past Mth, Reflecting Emphasis on High-yield Segments' Defensive Value
CICC continued to rate CSPC PHARMA as Outperform. Considering the rally in the industry's average valuation, the broker raised its target price by 26.5% to HKD8.6.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-04 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.